421 - 430 of 8093 Results
Title
Year
- Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials Initiative2024OPENTitle: Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials InitiativeJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 4Start Page: 657End Page: 666Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-230363Citation Count: 1
-
OPENTitle: Genetic and pharmacological reduction of CDK14 mitigates synucleinopathyJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 15Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41419-024-06534-8Citation Count: 3
-
OPENTitle: Orthogonal analysis of mitochondrial function in Parkinson’s disease patientsJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 15Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-024-06617-6Best OA location URL: https://www.nature.com/articles/s41419-024-06617-6.pdfCitation Count: 0
-
OPENTitle: RedOx regulation of LRRK2 kinase activity by active site cysteinesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00683-5Citation Count: 2
- Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's Disease2024OPENTitle: Alterations in Blood Methylome as Potential Epigenetic Biomarker in Sporadic Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 95Issue #: 6Start Page: 1162End Page: 1172Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26923Citation Count: 8
- DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s disease2024